Randomised clinical trial to determine the incidence of Cystoid Macular Oedema (CMO) after cataract surgery with Intraocular Cefuroxime.
Completed
- Conditions
- Surgery: CataractSurgeryCataract
- Registration Number
- ISRCTN13489716
- Lead Sponsor
- Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 120
Inclusion Criteria
120 patients, aged above 50 years having cataract surgery.
Exclusion Criteria
Not provided at time of registration
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What is the efficacy of intraocular cefuroxime in preventing CMO post-cataract surgery compared to standard care?
How do molecular targets of cefuroxime influence postoperative CMO incidence in cataract patients?
What biomarkers correlate with CMO risk after cataract surgery with intraocular cefuroxime administration?
What are the adverse event profiles of intraocular cefuroxime in cataract surgery trials?
How does intraocular cefuroxime compare to other antibiotic agents in reducing post-cataract CMO rates?